Health and Healthcare

Amgen : AMGN

All Amgen Articles

701 Articles

Chris Lange | Mar 3, 2018 at 8:40 AM EST

Major Biopharma Catalysts and FDA Events to Look For in March

24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in…

Chris Lange | Feb 28, 2018 at 9:15 AM EST

Major Biotechs Continue to See a Rising Tide of Short Interest

The short interest data are out for the most recent settlement date, February 15. Generally speaking, companies within the biotech…

Lee Jackson | Feb 28, 2018 at 8:40 AM EST

Jefferies Has 5 Stocks to Buy That Should Raise Dividends and Earnings

These five stocks come with upward earnings revisions and the potential for rising dividends. They all make good sense for…

Lee Jackson | Feb 14, 2018 at 8:10 AM EST

Top Analyst Has 3 Large Cap Biotechs to Buy as Massive Selling Subsides

With indiscriminate selling absolutely punishing some of the top large cap biotech stocks, one analyst says now is the time…

Chris Lange | Feb 12, 2018 at 9:15 AM EST

Major Biotechs See Rising Tide of Short Interest

The January 31 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Feb 5, 2018 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Boeing, Chevron, Exxon, Foot Locker, Lowe’s, Nokia, PayPal, Sprint, Wells Fargo and More

The top analyst upgrades, downgrades and other research calls from Monday include Amgen, Boeing, Chevron, Exxon Mobil, Foot Locker, Lowe's,…

Jon C. Ogg | Feb 2, 2018 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Alibaba, Alphabet, Amazon, Amgen, Apple, Mastercard, Nokia, Shopify, US Steel and More

The top analyst upgrades, downgrades and other research calls from Friday include Alibaba, Alphabet, Amazon, Amgen, Apple, Mastercard, Nokia, Shopify…

Chris Lange | Jan 25, 2018 at 10:05 AM EST

Short Sellers Raise the Stakes in Major Biotechs

The January 12 short interest data have been compared with the previous report, and short interest moves in the selected…

Jon C. Ogg | Jan 23, 2018 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Caterpillar, Dollar General, Duke Energy, GE, Honeywell, 3M, Netflix, Sprint and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Amgen, Caterpillar, Dollar General, Duke Energy, General Electric,…

Jon C. Ogg | Jan 17, 2018 at 4:15 PM EST

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Apple indicated that it will pay $38 billion in repatriation taxes under the new tax law. Apple says that it…

Chris Lange | Jan 11, 2018 at 9:50 AM EST

Short Sellers Grow More Selective on Major Biotechs

The December 29 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Jan 5, 2018 at 11:15 AM EST

Meet Merrill Lynch’s Top Biotech Picks for 2018

Merrill Lynch believes that this could be the year biotechs break out. The firm has a few picks, bad and…

Lee Jackson | Dec 31, 2017 at 10:15 AM EST

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be…

Chris Lange | Dec 28, 2017 at 9:05 AM EST

Major Biotechs See Surge in Short Interest

The December 15 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Dec 12, 2017 at 10:10 AM EST

Major Biotechs See Rising Tide in Short Interest

The November 30 short interest data have been compared with the previous report, and short interest in most of the…

1 … 16 17 18 19 20 … 47

Amgen : AMGN

All Amgen Articles

Major Biopharma Catalysts and FDA Events to Look For in March

Major Biotechs Continue to See a Rising Tide of Short Interest

Jefferies Has 5 Stocks to Buy That Should Raise Dividends and Earnings

Top Analyst Has 3 Large Cap Biotechs to Buy as Massive Selling Subsides

Major Biotechs See Rising Tide of Short Interest

Top Analyst Upgrades and Downgrades: Amgen, Boeing, Chevron, Exxon, Foot Locker, Lowe’s, Nokia, PayPal, Sprint, Wells Fargo and More

Top Analyst Upgrades and Downgrades: Alibaba, Alphabet, Amazon, Amgen, Apple, Mastercard, Nokia, Shopify, US Steel and More

Short Sellers Raise the Stakes in Major Biotechs

Top Analyst Upgrades and Downgrades: Amgen, Caterpillar, Dollar General, Duke Energy, GE, Honeywell, 3M, Netflix, Sprint and More

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Short Sellers Grow More Selective on Major Biotechs

Meet Merrill Lynch’s Top Biotech Picks for 2018

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

Major Biotechs See Surge in Short Interest

Major Biotechs See Rising Tide in Short Interest

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Amgen : AMGN

All Amgen Articles

Major Biopharma Catalysts and FDA Events to Look For in March

Major Biotechs Continue to See a Rising Tide of Short Interest

Jefferies Has 5 Stocks to Buy That Should Raise Dividends and Earnings

Top Analyst Has 3 Large Cap Biotechs to Buy as Massive Selling Subsides

Major Biotechs See Rising Tide of Short Interest

Top Analyst Upgrades and Downgrades: Amgen, Boeing, Chevron, Exxon, Foot Locker, Lowe’s, Nokia, PayPal, Sprint, Wells Fargo and More

Top Analyst Upgrades and Downgrades: Alibaba, Alphabet, Amazon, Amgen, Apple, Mastercard, Nokia, Shopify, US Steel and More

Short Sellers Raise the Stakes in Major Biotechs

Top Analyst Upgrades and Downgrades: Amgen, Caterpillar, Dollar General, Duke Energy, GE, Honeywell, 3M, Netflix, Sprint and More

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Short Sellers Grow More Selective on Major Biotechs

Meet Merrill Lynch’s Top Biotech Picks for 2018

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

Major Biotechs See Surge in Short Interest

Major Biotechs See Rising Tide in Short Interest

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings